Botanical species · safety record

Pilocarpus racemosus

The EFSA Compendium of Botanicals holds 6 constituent measurements for Pilocarpus racemosus. This page reports what those source records contain and how to reach them. It carries no effect estimate, no dose and no recommendation.

Accepted name in source: Pilocarpus racemosus Vahl

6Constituent measurements
0Safety records
3Cited sources
0Licensed products (Canada)

Also recorded as

Synonyms are carried from the source compendium. A species may be traded and studied under more than one name, which is exactly how a safety record gets lost.

Regulatory presence

No Health Canada licensed natural health product in the snapshot names this species as a medicinal ingredient under this exact binomial. Absence here means absence from this one register under this one name, not absence from trade, and not a safety verdict.

What the records describe

Constituents measured

  • Pilocarpine4
  • Alkaloids2

Plant parts

  • Leaves5
  • Stem1
  • stalk1

Preparations

  • Solvent extraction6

Recorded constituents

What analytical work has found in this species, at which plant part and preparation. A measured constituent is a fact about material, not about effect.

SubstancePlant partPreparationConcentrationAnalytical methodSource
AlkaloidsLeavesSolvent extraction0.96 PercentHigh Performance Liquid Chromatography (HPLC)/Liquid Chromatography (LC)Resolve DOI
AlkaloidsLeavesSolvent extraction0.96 PercentHPLC-MS/MSResolve DOI
PilocarpineLeavesSolvent extraction45.6 PercentHPLC-MS/MSResolve DOI
PilocarpineLeavesSolvent extraction45.6 PercentHigh Performance Liquid Chromatography (HPLC)/Liquid Chromatography (LC)Resolve DOI
PilocarpineLeavesSolvent extraction0.6871 Gram/kilogramGelpermeation, High Performance Thin Layer Chromatography (HPTLC)No resolvable identifier
PilocarpineStem / stalkSolvent extraction1.65 Gram/kilogramGelpermeation, High Performance Thin Layer Chromatography (HPTLC)No resolvable identifier

Cited sources

The literature the compendium cites for this species. Metatron Health has no relationship with these authors or journals and earns nothing from citing them.

  1. Helena Frankland Sawaya, Alexandra Christine., Vaz, Boniek Gontijo., Eberlin, Marcos Nogueira., Mazzafera, Paulo. Screening species of Pilocarpus (Rutaceae) as sources of pilocarpine and other imidazole alkaloids . Genetic resources and crop evolution, 2011, vol. 58, no. 3, p. 471-480. DOI
  2. Hill, Armando Pay., Dominicis, Ma. Elena., Oquendo, Marledis., Sarduy, Rosa. Isolation of pilocarpine from Pilocarpus racemosus Vahl. Revista cubana de farmacia, 1995, vol. 29, no. 2, p. 123-125.
  3. Rastogi, N., Abaul, J., Goh, KS., Devallois, A., Philogene, E., Bourgeois, P. Antimycobacterial activity of chemically defined natural substances from the Caribbean flora in Guadeloupe . Fems immunology and medical microbiology, 1998, vol. 20, no. 4, p. 267-273. DOI

Boundary

A constituent measurement is a fact about material at a stated preparation, not a statement about what that material does in a person. An adverse-effect or genotoxicity record is an observation reported in a source, most often in an animal or laboratory model. Neither is a Metatron Health conclusion about causality, human risk or benefit, and the absence of a record is not proof that a preparation is safe. Nothing here is diagnosis, prescribing or individual medical care.

Continue